Published in Klin Wochenschr on May 15, 1989
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene (1991) 2.71
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol (1998) 2.60
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest (1989) 2.25
Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation (1996) 1.94
C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol (2000) 1.88
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study. Eur Heart J (2002) 1.65
Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol (1991) 1.63
Association between rheology and components of lipoproteins in human blood. Results from the MONICA project. Circulation (1992) 1.54
Pharmacokinetics of oral and intravenous rifampicin during chronic administration. Klin Wochenschr (1985) 1.46
Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome. Eur Heart J (2001) 1.43
Time-dependent changes of heart rate variability after percutaneous transluminal angioplasty. Am Heart J (1998) 1.41
Pharmacologic blockade of the left stellate ganglion using a drug-reservoir-pump system. Chest (1990) 1.38
Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg (2008) 1.35
The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res (1974) 1.28
Does fall in tissue glucose precede fall in blood glucose? Diabetologia (1996) 1.26
Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol (2001) 1.22
Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl (1988) 1.19
PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Circulation (2001) 1.18
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. J Intern Med (2006) 1.15
Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14
Modulation of iodide uptake by dialkyl phthalate plasticisers in FRTL-5 rat thyroid follicular cells. Mol Cell Endocrinol (2005) 1.09
Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man. Am J Dig Dis (1976) 1.09
Action of streptozotocin on insulin and glucagon responses of rat islets. Horm Metab Res (1970) 1.06
Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res (1999) 1.06
Effects of somatostatin on gastric secretion and gastrin release in man. Digestion (1975) 1.05
Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res (1974) 1.00
Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs. Regul Pept (1980) 0.98
Characterization of the sodium currents in isolated human cardiocytes. Pflugers Arch (1994) 0.97
[Resynthesis of insulin from the preoxidized A chain and reduced B chain]. Justus Liebigs Ann Chem (1966) 0.97
Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol (1996) 0.97
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells. Thorax (2003) 0.97
Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J (1995) 0.97
A remark on the high-conductance calcium-activated potassium channel in human endothelial cells. Res Exp Med (Berl) (1998) 0.97
Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care (1995) 0.97
Spatial differences of the duration of ventricular late fields in the signal-averaged magnetocardiogram in patients with ventricular late potentials. Pacing Clin Electrophysiol (1993) 0.95
Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest (1979) 0.95
Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol (2006) 0.95
Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol (1993) 0.95
Lactic acid permeation rate in working gastrocnemii of dogs during metabolic alkalosis and acidosis. Pflugers Arch (1975) 0.94
[Age-dependent compound construction of the lumbar vertebrae. An analysis of structure and form (author's transl)]. Virchows Arch A Pathol Anat Histol (1980) 0.94
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol (1989) 0.94
Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler Thromb Vasc Biol (1997) 0.94
Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol (1994) 0.93
Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol (2001) 0.93
New method for accurate calculation of regurgitant flow rate based on analysis of Doppler color flow maps of the proximal flow field. Validation in a canine model of mitral regurgitation with initial application in patients. J Am Coll Cardiol (1996) 0.92
Cloning of a functional promoter of the human sodium/iodide-symporter gene. Biochem J (1998) 0.92
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab (1988) 0.92
A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol Endocrinol (1992) 0.92
Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med (1977) 0.92
Magnetocardiography: three-dimensional localization of the origin of ventricular late fields in the signal averaged magnetocardiogram in patients with ventricular late potentials. Eur Heart J (1993) 0.91
Thyroid transcription factor 1 and Pax8 synergistically activate the promoter of the human thyroglobulin gene. J Mol Endocrinol (2001) 0.91
Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Horm Metab Res (1971) 0.91
Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology (1990) 0.90
An approach to direct detection of sinus nodal activity in man. J Electrocardiol (1979) 0.89
Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis (1996) 0.89
A human arterial organ culture model of postangioplasty restenosis: results up to 56 days after ballooning. Atherosclerosis (1999) 0.89
[The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)]. MMW Munch Med Wochenschr (1976) 0.89
Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma. Cancer Chemother Pharmacol (1989) 0.89
Stimulation of H-3-leucine incorporation into the proinsulin and insulin fraction of isolated pancreatic mouse islets in the presence of glucagon, theophylline and cyclic AMP. Diabetes (1973) 0.89
[Metabolic changes in zero-diet]. Internist (Berl) (1970) 0.89
Transcriptional regulation of the human sodium/iodide symporter gene by Pax8 and TTF-1. Exp Clin Endocrinol Diabetes (2001) 0.89
On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia (1992) 0.88
Peripheral autoregulation of thyromimetic activity in man. Horm Metab Res (1988) 0.88
On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res (1993) 0.88
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL). Oncogene (1995) 0.88
Leukocyte attack in a 3D human coronary in-vitro model. Coron Artery Dis (2001) 0.88
Color Doppler echocardiographic determination of mitral regurgitant flow from the proximal velocity profile of the flow convergence region. Am J Cardiol (1993) 0.88
Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88
The effect of serotonin on in vitro insulin secretion and biosynthesis in mice. Diabetologia (1974) 0.87
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87
Molecular cloning of the translocation breakpoint in T-ALL 11;14 (p13;q11): genomic map of TCR alpha and delta region on chromosome 14q11 and long-range map of region 11p13. Hum Genet (1989) 0.87
A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol (1999) 0.86
A coronary porcine organ culture system for studies of postangioplasty cell proliferation. Coron Artery Dis (1995) 0.86
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology (1991) 0.86
Direct pulsed field gel electrophoresis of Wilms' tumors shows that DNA deletions in 11p13 are rare. Genes Chromosomes Cancer (1991) 0.86
High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis. Coron Artery Dis (1997) 0.86
[Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy]. Anaesthesist (2008) 0.86
Chemical ablation by subendocardial injection of ethanol via catheter--preliminary results in the pig heart. Eur Heart J (1991) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism (1978) 0.85
Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release. Horm Metab Res (1992) 0.85
Pericardial synovial sarcoma mimicking pericarditis in findings of cardiac magnetic resonance imaging. Int J Cardiol (2007) 0.85
Intracoronary beta-irradiation with a liquid (188)re-filled balloon: six-month results from a clinical safety and feasibility study. Circulation (2000) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron (1993) 0.85